Looking forward to seeing everyone at #astro23. Drop by our #radonc @MDAndersonNews (booth 2325) to meet our faculty and our president, @ppisters. We will be presenting 51 abstracts throughout the meeting to advance our goal to #endcancer. @ASTRO_org
Be sure to visit the MD Anderson Blood Drive during #SOHO2023! Our blood collection staff will be in room 310A at the George R. Brown Convention Center Wednesday – Thursday, Sept. 6-7 from 10 a.m. to 2 p.m.
Join me as I present “New HER2 Classification Impact to the Management of Low HER2 Metastatic Breast Cancer” at the @MDAndersonNews Physician Advisory Council!
Virtual Meeting Today at 5:30 – 6:30 p.m. CST.
Register here: https://t.co/ZWrqL3KanE
Collaborating with colleagues to share information on @MDAndersonNews 1600+ clinical trials with #ASCO22 attendees. Search our clinical trial database at https://t.co/OsUylbNjaq. #EndCancer
MD Anderson is committed to being a world-leader in cancer care, research, prevention and education. Our Strategy lays the framework for our future.
Hear from MD Anderson President Dr. Peter WT Pisters today from 11 a.m. to 1 p.m. at booth 6122. @PPisters#ASCO22#EndCancer
I’ve talked with @JimAllisonPhD many times about how we can advance immunotherapy into the future. Today @MDAndersonNews, we will see that vision become a reality. Tune in at 9 a.m. for a special announcement about our bold path forward. #EndCancer
A wonderful inspirational article on one of my beloved colleagues @S_Champagne1960.
Multiple myeloma survivor and employee: ‘MD Anderson really is the best’ https://t.co/6g1efqrK8x
Findings from Dr. Sattva Neelapu and Dr. Jason Westin show efficacy of moving CAR T cell therapy to earlier lines of therapy.
Read the latest results from the ZUMA-5, ZUMA-12 and the ZUMA-7 clinical trials: https://t.co/5EFge8WIkP #ASH12@lymphoma_doc#EndCancer